Unknown

Dataset Information

0

Heterozygous Mutations in MAP3K7, Encoding TGF-?-Activated Kinase 1, Cause Cardiospondylocarpofacial Syndrome.

ABSTRACT: Cardiospondylocarpofacial (CSCF) syndrome is characterized by growth retardation, dysmorphic facial features, brachydactyly with carpal-tarsal fusion and extensive posterior cervical vertebral synostosis, cardiac septal defects with valve dysplasia, and deafness with inner ear malformations. Whole-exome sequencing identified heterozygous MAP3K7 mutations in six distinct CSCF-affected individuals from four families and ranging in age from 5 to 37 years. MAP3K7 encodes transforming growth factor ? (TGF-?)-activated kinase 1 (TAK1), which is involved in the mitogen-activated protein kinase (MAPK)-p38 signaling pathway. MAPK-p38 signaling was markedly altered when expression of non-canonical TGF-?-driven target genes was impaired. These findings support the loss of transcriptional control of the TGF-?-MAPK-p38 pathway in fibroblasts obtained from affected individuals. Surprisingly, although TAK1 is located at the crossroad of inflammation, immunity, and cancer, this study reports MAP3K7 mutations in a developmental disorder affecting mainly cartilage, bone, and heart.

SUBMITTER: Le Goff C 

PROVIDER: S-EPMC4974068 | biostudies-literature | 2016 Aug

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Heterozygous Mutations in MAP3K7, Encoding TGF-β-Activated Kinase 1, Cause Cardiospondylocarpofacial Syndrome.

Le Goff Carine C   Rogers Curtis C   Le Goff Wilfried W   Pinto Graziella G   Bonnet Damien D   Chrabieh Maya M   Alibeu Olivier O   Nistchke Patrick P   Munnich Arnold A   Picard Capucine C   Cormier-Daire Valérie V  

American journal of human genetics 20160714 2

Cardiospondylocarpofacial (CSCF) syndrome is characterized by growth retardation, dysmorphic facial features, brachydactyly with carpal-tarsal fusion and extensive posterior cervical vertebral synostosis, cardiac septal defects with valve dysplasia, and deafness with inner ear malformations. Whole-exome sequencing identified heterozygous MAP3K7 mutations in six distinct CSCF-affected individuals from four families and ranging in age from 5 to 37 years. MAP3K7 encodes transforming growth factor β  ...[more]

Similar Datasets

Unknown Activating Mutations in PAK1, Encoding p21-Activated Kinase 1, Cause a Neurodevelopmental Disorder.
| S-EPMC6174322 | biostudies-literature
Unknown Homozygous and compound-heterozygous mutations in TGDS cause Catel-Manzke syndrome.
| S-EPMC4259972 | biostudies-literature
Unknown Heterozygous Loss-of-Function Mutations in DLL4 Cause Adams-Oliver Syndrome.
| S-EPMC4564989 | biostudies-literature
Unknown Mutations in KAT6B, encoding a histone acetyltransferase, cause Genitopatellar syndrome.
| S-EPMC3276659 | biostudies-literature
Unknown Compound heterozygous PNPLA6 mutations cause Boucher-Neuhauser syndrome with late-onset ataxia.
| S-EPMC4245359 | biostudies-literature
Unknown Compound heterozygous mutations in PMFBP1 cause acephalic spermatozoa syndrome: A case report.
| S-EPMC9791525 | biostudies-literature
Unknown Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi-Goutieres syndrome.
| S-EPMC1852703 | biostudies-literature
Unknown Case Report: Novel Compound Heterozygous <i>RNASEH2B</i> Mutations Cause Aicardi-Goutieres Syndrome.
| S-EPMC8107470 | biostudies-literature
Unknown Mutations in NBEAL2, encoding a BEACH protein, cause gray platelet syndrome.
| S-EPMC6050511 | biostudies-literature
Unknown Mutations in STAMBP, encoding a deubiquitinating enzyme, cause microcephaly-capillary malformation syndrome.
| S-EPMC4000253 | biostudies-literature